Haga-gun, Japan

Ren Kimura

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Kao Corporation. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ren Kimura. Retrieved from https://idiyas.com/inventor/ren-kimura-s6z62fhe

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ren Kimura: Innovator in Dementia Diagnosis

Introduction

Ren Kimura is a notable inventor based in Haga-gun, Japan. He has made significant contributions to the field of medical diagnostics, particularly in the area of dementia. His innovative approach focuses on providing accurate and minimally invasive methods for diagnosing dementia or mild cognitive impairment.

Latest Patents

Ren Kimura holds a patent for an "Examination method for dementia or risk thereof." This patent outlines a method that includes measuring the amount of stereoisomers of proline in a biological sample collected from a subject. The process involves comparing the level of D-proline with a reference value to assess the likelihood of mild cognitive impairment or dementia.

Career Highlights

Ren Kimura is associated with Kao Corporation, where he applies his expertise in medical diagnostics. His work has been instrumental in advancing the understanding and detection of cognitive impairments, which can significantly impact patient care and treatment options.

Collaborations

Ren collaborates with talented individuals such as Satoko Soga and Noriyasu Ota. Their combined efforts contribute to the innovative research and development at Kao Corporation.

Conclusion

Ren Kimura's work in developing a method for diagnosing dementia showcases his commitment to improving healthcare through innovation. His contributions are vital in the ongoing battle against cognitive decline, and his patent reflects a significant advancement in medical diagnostics.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…